ZA941308B - Bisacodyl dosage form - Google Patents
Bisacodyl dosage formInfo
- Publication number
- ZA941308B ZA941308B ZA941308A ZA941308A ZA941308B ZA 941308 B ZA941308 B ZA 941308B ZA 941308 A ZA941308 A ZA 941308A ZA 941308 A ZA941308 A ZA 941308A ZA 941308 B ZA941308 B ZA 941308B
- Authority
- ZA
- South Africa
- Prior art keywords
- colon
- bisacodyl
- dosage form
- lumen
- small intestine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Nanotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medical Informatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Crystallography & Structural Chemistry (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Epoxy Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2341293A | 1993-02-26 | 1993-02-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA941308B true ZA941308B (en) | 1994-09-30 |
Family
ID=21814950
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA941308A ZA941308B (en) | 1993-02-26 | 1994-02-25 | Bisacodyl dosage form |
Country Status (20)
Country | Link |
---|---|
US (1) | US5670158A (pt) |
EP (1) | EP0686034B1 (pt) |
JP (1) | JP3725539B2 (pt) |
CN (1) | CN1047075C (pt) |
AT (1) | ATE201991T1 (pt) |
AU (1) | AU6251094A (pt) |
BR (1) | BR9405836A (pt) |
CA (1) | CA2156726C (pt) |
CZ (1) | CZ286051B6 (pt) |
DE (1) | DE69427466T2 (pt) |
DK (1) | DK0686034T3 (pt) |
ES (1) | ES2157253T3 (pt) |
GR (1) | GR3036042T3 (pt) |
HU (1) | HUT72975A (pt) |
IL (1) | IL108705A (pt) |
PL (1) | PL176846B1 (pt) |
PT (1) | PT686034E (pt) |
SK (1) | SK104895A3 (pt) |
WO (1) | WO1994018973A1 (pt) |
ZA (1) | ZA941308B (pt) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5914132A (en) * | 1993-02-26 | 1999-06-22 | The Procter & Gamble Company | Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery |
US5656290A (en) * | 1993-02-26 | 1997-08-12 | The Procter & Gamble Company | Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery |
US5651983A (en) * | 1993-02-26 | 1997-07-29 | The Procter & Gamble Company | Bisacodyl dosage form for colonic delivery |
US5843479A (en) * | 1993-02-26 | 1998-12-01 | The Procter & Gamble Company | Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery |
US6028190A (en) | 1994-02-01 | 2000-02-22 | The Regents Of The University Of California | Probes labeled with energy transfer coupled dyes |
GB9412394D0 (en) | 1994-06-21 | 1994-08-10 | Danbiosyst Uk | Colonic drug delivery composition |
US6166024A (en) * | 1995-03-30 | 2000-12-26 | Mayo Foundation For Medical Education And Research | Use of topical azathioprine and thioguanine to treat colorectal adenomas |
CA2271560C (en) * | 1996-11-15 | 2003-09-23 | Mayo Foundation For Medical Education And Research | Pharmaceutical dosage form for colonic delivery |
AR017512A1 (es) * | 1997-08-22 | 2001-09-12 | Smithkline Beecham Corp | Tabletas de metilcelulosa rapidamente desintegrables para administracion por via oral y procedimiento para prepararlas |
IT1296980B1 (it) * | 1997-12-17 | 1999-08-03 | Istituto Pirri S R L | Capsula doppia come forma farmaceutica per la somministrazione di principi attivi in terapie multiple |
DE19913606A1 (de) * | 1999-03-25 | 2000-09-28 | Basf Ag | Pulverförmige Solubilisationshilfsstoffe für feste pharmazeutische Darreichungsformen |
CA2371940C (en) * | 1999-03-31 | 2008-07-15 | Janssen Pharmaceutica N.V. | Pregelatinized starch in a controlled release formulation |
CN1529587B (zh) * | 2001-05-30 | 2010-05-12 | 欧洲凯尔特公司 | 含有粪便软化剂泊洛沙姆和包有肠溶衣的比沙可定颗粒的药物组合物 |
GB0124953D0 (en) * | 2001-10-17 | 2001-12-05 | Novartis Ag | Organic Compounds |
US20160184358A9 (en) * | 2002-07-15 | 2016-06-30 | George M. Halow | Bowel cleansing composition |
US7291324B2 (en) * | 2002-10-22 | 2007-11-06 | Braintree Laboratories Inc. | Method of bowel cleansing |
PT2279729T (pt) * | 2003-07-17 | 2016-09-22 | Banner Life Sciences Llc | Preparações de libertação controlada |
KR101323478B1 (ko) * | 2004-03-10 | 2013-10-31 | 다이쇼 세이야꾸 가부시끼가이샤 | 수난용성 약물 배합 고형 제제 |
DK1976520T3 (da) * | 2005-12-29 | 2011-06-27 | Braintree Lab | Et sæt omfattende et osmotisk laksativ og et stimulerende laksativ til forberedelse af kolon til virtuel kolonskopi |
US8211417B1 (en) | 2009-10-31 | 2012-07-03 | Harry Snady | Method of bowel cleansing |
WO2014016671A2 (en) | 2012-07-27 | 2014-01-30 | Redhill Biopharma Ltd. | Formulations and methods of manufacturing formulations for use in colonic evacuation |
DE102014017936A1 (de) | 2014-12-05 | 2016-06-09 | Tracto-Technik Gmbh & Co. Kg | Erdbohrvorrichtung |
WO2017048566A1 (en) | 2015-09-15 | 2017-03-23 | C.B. Fleet Company, Incorporated | Bisacodyl compositions and delivery apparatus |
CN109984993A (zh) * | 2018-01-03 | 2019-07-09 | 药大制药有限公司 | 一种提升比沙可啶栓质量的处方及制备方法 |
WO2022219573A2 (en) * | 2021-04-15 | 2022-10-20 | Rolling Pastures Pte. Ltd. | Microencapsulation wall material, suspension core capsule, edible capsule with electronics, methods and a production system for producing the same |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE818022C (de) * | 1950-05-05 | 1951-10-22 | Otto Hellmann | Papierkorb zur Aufnahme von Papier und Abfaellen |
US2764590A (en) * | 1952-03-17 | 1956-09-25 | Thomae Gmbh Dr K | Certain 4, 4'-disubstituted-diphenylpyridyl methanes and process |
US3927195A (en) * | 1974-01-31 | 1975-12-16 | Lilly Industries Ltd | Production of capsules |
JPS5799521A (en) * | 1980-12-11 | 1982-06-21 | Eisai Co Ltd | Solid composition containing bisacodyl |
JPS59193816A (ja) * | 1983-04-19 | 1984-11-02 | Morishita Jintan Kk | 腸溶性軟カプセルの製造法 |
IE58110B1 (en) * | 1984-10-30 | 1993-07-14 | Elan Corp Plc | Controlled release powder and process for its preparation |
GB8613688D0 (en) * | 1986-06-05 | 1986-07-09 | Euro Celtique Sa | Pharmaceutical composition |
JPS6320409A (ja) * | 1986-07-15 | 1988-01-28 | Nippon Kokan Kk <Nkk> | 取鍋精錬方法 |
US4810707A (en) * | 1987-02-25 | 1989-03-07 | Meditech Pharmaceuticals, Inc. | Herpes simplex treatment |
JPS63258815A (ja) * | 1987-04-16 | 1988-10-26 | Kiyuushin Seiyaku Kk | ビサコジル含有固形組成物 |
JPH0672106B2 (ja) * | 1987-04-22 | 1994-09-14 | 花王株式会社 | 緩下剤組成物 |
JP2782691B2 (ja) * | 1987-09-29 | 1998-08-06 | ワーナー−ランバート・コンパニー | 腸溶製剤の安定化 |
US5068110A (en) * | 1987-09-29 | 1991-11-26 | Warner-Lambert Company | Stabilization of enteric coated dosage form |
DE3818022C2 (de) * | 1988-05-24 | 1994-04-28 | Guenter Stephan | Weichgelatinekapsel |
JPH0818971B2 (ja) * | 1989-02-16 | 1996-02-28 | ブリティッシュ・テクノロジー・グループ・リミテッド | 投与製剤 |
GB8903564D0 (en) * | 1989-02-16 | 1989-04-05 | Rashid Abdul | Drug dispensing device |
GB9004702D0 (en) * | 1990-03-02 | 1990-04-25 | Polysystems Limited | Dispensing device |
-
1994
- 1994-02-10 DE DE69427466T patent/DE69427466T2/de not_active Expired - Fee Related
- 1994-02-10 SK SK1048-95A patent/SK104895A3/sk unknown
- 1994-02-10 BR BR9405836A patent/BR9405836A/pt not_active Application Discontinuation
- 1994-02-10 AT AT94909814T patent/ATE201991T1/de not_active IP Right Cessation
- 1994-02-10 AU AU62510/94A patent/AU6251094A/en not_active Abandoned
- 1994-02-10 CZ CZ952049A patent/CZ286051B6/cs not_active IP Right Cessation
- 1994-02-10 HU HU9502492A patent/HUT72975A/hu unknown
- 1994-02-10 PL PL94310355A patent/PL176846B1/pl unknown
- 1994-02-10 EP EP94909814A patent/EP0686034B1/en not_active Expired - Lifetime
- 1994-02-10 JP JP51930894A patent/JP3725539B2/ja not_active Expired - Fee Related
- 1994-02-10 CN CN94191310A patent/CN1047075C/zh not_active Expired - Fee Related
- 1994-02-10 ES ES94909814T patent/ES2157253T3/es not_active Expired - Lifetime
- 1994-02-10 CA CA002156726A patent/CA2156726C/en not_active Expired - Fee Related
- 1994-02-10 DK DK94909814T patent/DK0686034T3/da active
- 1994-02-10 WO PCT/US1994/002081 patent/WO1994018973A1/en active IP Right Grant
- 1994-02-10 PT PT94909814T patent/PT686034E/pt unknown
- 1994-02-18 IL IL108705A patent/IL108705A/en not_active IP Right Cessation
- 1994-02-25 ZA ZA941308A patent/ZA941308B/xx unknown
-
1995
- 1995-11-15 US US08/558,338 patent/US5670158A/en not_active Expired - Fee Related
-
2001
- 2001-06-14 GR GR20010400748T patent/GR3036042T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2156726C (en) | 2000-10-17 |
GR3036042T3 (en) | 2001-09-28 |
DK0686034T3 (da) | 2001-08-27 |
JP3725539B2 (ja) | 2005-12-14 |
US5670158A (en) | 1997-09-23 |
PL310355A1 (en) | 1995-12-11 |
CN1047075C (zh) | 1999-12-08 |
SK104895A3 (en) | 1996-06-05 |
BR9405836A (pt) | 1996-01-16 |
HU9502492D0 (en) | 1995-10-30 |
CZ286051B6 (cs) | 1999-12-15 |
WO1994018973A1 (en) | 1994-09-01 |
DE69427466D1 (de) | 2001-07-19 |
EP0686034B1 (en) | 2001-06-13 |
HUT72975A (en) | 1996-06-28 |
IL108705A (en) | 1998-04-05 |
JPH08509958A (ja) | 1996-10-22 |
PT686034E (pt) | 2001-10-30 |
CA2156726A1 (en) | 1994-09-01 |
DE69427466T2 (de) | 2002-04-25 |
ATE201991T1 (de) | 2001-06-15 |
CN1118571A (zh) | 1996-03-13 |
EP0686034A1 (en) | 1995-12-13 |
ES2157253T3 (es) | 2001-08-16 |
PL176846B1 (pl) | 1999-08-31 |
IL108705A0 (en) | 1994-05-30 |
AU6251094A (en) | 1994-09-14 |
CZ204995A3 (en) | 1996-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GR3036042T3 (en) | Bisacodyl dosage form | |
HK1036018A1 (en) | Preventives or remedies for inflammatory intestinal diseases containing as the active ingredient il-6 antagonists | |
MXPA03008760A (es) | Agentes terapeuticos para enfermedades inflamatorias de los intestinos. | |
DE69205971D1 (de) | Orale dosierungsform mit verzögerter wirkstoffabgabe für die behandlung von intestinalen krankheiten. | |
ATE213936T1 (de) | Pharmazeutische dosisform mit mehrfacher darmlöslicher polymerbeschichtung zur wirkstoffabgabe im kolon | |
ATE234079T1 (de) | Pharmazeutische dosierungsform mit mehrfachen enterischen polymer-überzügenzur abgabe im kolon | |
NZ502445A (en) | Control of acidic gut syndrome | |
HU9202808D0 (en) | Improvement of down-regulqtion of autoimmunic diseases by means of oral dosing of autoantigenes | |
ATE260646T1 (de) | Schnell zerfallende orale dosierungsform | |
AU2003243545A8 (en) | Prevention and/or treatment of inflammatory bowel disease using pyy or agonists thereof | |
KR900015724A (ko) | 메베버린 용량 형태 | |
ES2149733T1 (es) | Composicion farmaceutica oral con liberacion modificada que contiene 5-asa y metodo para el tratamiento de enfermedades intestinales. | |
CA2032475A1 (en) | Pharmaceutical preparations for oral administration that are adapted to release the drug at appropriate sites in the intestines | |
CO4130184A1 (es) | Forma de dosificacion de bisacodyl | |
HU9300244D0 (en) | Method for producing chemotherapeutical agent of antitumourous effect originated of plants and medical preparatives containing it | |
JPS577422A (en) | Crocosmia aurea "plach" | |
SE9003096D0 (sv) | Device for administering a physiologically active substance to the gastro-intestinal tract | |
Rennie | The persistence of African swine fever virus in the argasid tick Ornithodoros moubata. | |
IL124730A (en) | Compositions for the treatment of gastrointestinal disorders comprising a bismuth compound and one or more antimicrobials, and the use of bismuth and an antimicrobial compound for the preparation of such compositions | |
Lamberti et al. | Answer: A Strange Case of Parkinsonism in a Gastroenterologist | |
JPS6438027A (en) | Remedy for cancer | |
ES8706028A1 (es) | Procedimiento de preparacion de nuevas composiciones sinergeticas antimicrobianas que contienen aritetraciclina y un acido organico de acitividad antimicrobiana. | |
Quarto et al. | On epidemiology of Yersinia enterocolitica. Note II. Research carried out on cattle farms. | |
Faro et al. | Study of Trimethoprim/Sulfamethoxypyrazine Association in the Treatment of Pneumonia. | |
Tsymbalar et al. | Pathogenetic treatment in combined therapy of patients with tuberculous pleurisy. |